---
$id: https://graph.org.ai/products/commodity/51263132
$type: Product
source: UNSPSC
code: "51263132"
title: "Pargolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pargolol

**UNSPSC Code**: 51263132
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5OPO851W5L. European Medicines Agency schedules Pargolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09625MIG. Pargolol generally arises in the molecular formula C16H23NO3. The term PARGOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17.) PARGOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pargolol under HS 29221980 and SITC 51461. As of Q4 2014, PARGOLOL remains the US FDA Preferred Term for this commodity. Pargolol bears US NLM identifiers UMLS ID C0070112 and NCI Concept Code C66321. SMILES: OC(CNC(C)(C)C)COC1C(OCC#C)CCCC1.

